In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system

Bioconjugate Chemistry

Volumn 20, Issue 7, 2009, Pages 1299-1306

  Kim, Eun Mi ^a   Park, Eun Hye ^a   Cheong, Su Jin ^a   Lee, Chang Moon ^a   Jeong, Hwan Jeong ^a   Dong, Wook Kim ^a   Seok, Tae Lim ^a   Sohn, Myung Hee ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOOCTANOIC ACID; BINDING PROTEIN; C MET BINDING PEPTIDE; CELL SURFACE RECEPTOR; CHIMERIC PROTEIN; CYANINE DYE; FLUORESCENT DYE; MESSENGER RNA; OCTANOIC ACID DERIVATIVE; PEPTIDE; SCATTER FACTOR RECEPTOR; SODIUM IODIDE I 125; TRIGLYCINE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CELL; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG TARGETING; FLUORESCENCE; GLIOMA; HUMAN; ISOTOPE LABELING; MOLECULAR IMAGING; MOUSE; NEOPLASM; NONHUMAN; NUDE MOUSE; PEPTIDE SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

MUS;

EID: 67650658077     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc8005539     Document Type: Article

References (31)

1. Okarvi, S. M. (2004) Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases. Med. Res. Rev. 24, 357-397.
2. Christensen, J. G., Burrows, J., and Salgia, R. (2005) c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 225, 1-26.
3. Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G. F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925.
4. Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., and Salgia, R. (2002) Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13, 41-59.
5. Yang, Y., Wislez, M., Fujimoto, N., Prudkin, L., Izzo, J. G., Uno, F., Ji, L., Hanna, A. E., Langley, R. R., Liu, D., Johnson, F. M., Wistuba, I., and Kurie, J. M. (2008) A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung pre-malignancy induced by mutant K-ras. Mol. Cancer Ther. 7, 952-960.
6. Kim, K., Hur, Y., Ryu, E. K., Rhim, J. H., Choi, C. Y., Baek, C. M., Lee, J. H., and Chung, J. (2007) A neutralizable epitope is induced on HGF upon its interaction with its receptor cMet. Biochem. Biophy. Res. Commun. 354, 115-121.
7. Hsu, A. R., Hou, L. C., Veeravagu, A., Greve, J. M., Vogel, H., Tse, V., and Chen, X. (2004) In vivo near-infrared fluorescence imaging of integrin αvβ3 in brain tumor xenografts. Cancer Res. 64, 8009-8014.
8. Levi, J., Cheng, Z., Gheysens, O., Patel, M., Chan, C. T., Wang, Y., Namavari, M., and Gambhir, S. S. (2007) Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjugate Chem. 18, 628-634.
9. Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., Cohn, L. H., Bawendi, M. G., and Frangioni, J. V. (2004) Near infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22, 93-97.
10. 3 expression in living mice. Bioconjugate Chem. 16, 1433-1441.
11. Ke, S., Wen, X., Gurfinkel, M., Charnsangavej, C., Wallace, S., Sevick-Muraca, E. M., and Li, C. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 63, 78707875.
12. Ntziachristos, V., Tung, C.-H., Bremer, C., and Weissleder, R. (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat. Med. 8, 757-760.
13. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A., Jr. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378.
14. Kim, E. M., Park, E. H., Cheong, S. J., Lee, C. M., Kim, D., Jeong H. J., Lim, S., Sohn, M. H., Kim, K., Chung, J. (2009) Characterization, biodistribution, and small-animal SPECT of I-125 labeled cMBP in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts. Nucl. Med. Biol., in press.
15. Weimar, I. S., Weijer, K., van den Berk, P. C., Muller, E. J., Miranda, N., Bakker, A. Q., Heemskerk, M. H., Hekman, A., de Gast, G. C., and Gerritsen, W. R. (1999) HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice. Br. J. Cancer 81, 43-53.
16. Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., and Vande Woude, G. F. (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311, 29-33.
17. Miller, C. T., Lin, L., Casper, A. M., Lim, J., Thomas, D. G., Orringer, M. B., Chang, A. C., Chambers, A. F., Giordano, T. J., Glover, T. W., and Beer, D. G. (2006) Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25, 409-418.
18. Stellrecht, C. M., Phillip, C. J., Cervantes-Gomez, F., and Gandhi, V. (2007) Multiple myeloma cell killing by depletion of the MET receptor tyrosine kinase. Cancer Res. 67, 9913-9920.
19. Garcia, S., Dales, J. P., Charafe-Jauffret, E., Carpentier-Meunier, S., Andrac-Meyer, L., Jacquemier, J., Andonian, C., Lavaut, M. N., Allasia, C., Bonnier, P., and Charpin, C. (2007) Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. Int. J. Oncol. 31, 49-58.
20. Puri, N., Ahmed, S., Janamanchi, V., Tretiakova, M., Zumba, O., Krausz, T., Jagadeeswaran, R., and Salgia, R. (2007) c-Met is a potentially new therapeutic target for treatment of human melanoma. Clin. Cancer Res. 13, 2246-2253.
21. You, W. K., and McDonald, D. M. (2008) The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. J. Biochem. Mol. Biol. 41, 833-839.
22. Migliore, C., and Giordano, S. (2008) Molecular cancer therapy: Can our expectation be MET? Eur. J. Cancer 44, 641-651.
23. Date, K., Matsumoto, K., Shimura, H., Tanaka, M., and Nakamura, T. (1997) HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. 420, 1-6.
24. Burgess, T., Coxon, A., Meyer, S., Sun, J., Rex, K., Tsuruda, T., Chen, Q., Ho, S. Y., Li, L., Kaufman, S., McDorman, K., Cattley, R. C., Sun, J., Elliott, G., Zhang, K., Feng, X., Jia, X. C., Green, L., Radinsky, R., and Kendall, R. (2006) Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors. Cancer Res. 66, 1721-1729.
25. Kim, K. J., Wang, L., Su, Y. C., Gillespie, G. Y., Salhotra, A., Lal, B., and Laterra, J. (2006) Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin. Cancer Res. 12, 1292-1298.
26. Berthou, S., Aebersold, D. M., Schmidt, L. S., Stroka, D., Heigl, C., Streit, B., Stalder, D., Gruber, G., Liang, C., Howlett, A. R., Candinas, D., Greiner, R. H., Lipson, K. E., and Zimmer, Y. (2004) The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants. Oncogene 23, 5387-5393.
27. Ma, P. C., Schaefer, E., Christensen, J. G., and Salgia, R. (2005) A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin. Clin. Cancer Res. 11, 2312-2319.
28. Perk, L. R., Stigter-van, Walsum, M., Visser, G. W., Kloet, R. W., Vosjan, M. J., Leemans, C. R., Giaccone, G., Albano, R., Comoglio, P. M., and van Dongen, G. A. (2008) Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30. Eur. J. Nucl. Med. Mol. Imaging 35, 1857-1867.
29. Towner, R. A., Smith, N., Doblas, S., Tesiram, Y., Garteiser, P., Saunders, D., Cranford, R., Silasi-Mansat, R., Herlea, O., Ivanciu, L., Wu, D., and Lupu, F. (2008) In vivo detection of c-Met expression in a rat C6 glioma model. J. Cell. Mol. Med. 12, 174186.
30. Di Renzo, M. F., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Medico, E., Gaglia, P., Zara, P., and Cormoglio, P. M. (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6, 1997-2003.
31. Sonnenberg, E., Meyer, D., Weidner, K. M., and Birchmeier, C. (1993) Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123, 223-235.